NOTE: this month’s feature focuses on a survivor’s recent experience as an ovarian cancer advocate in Washington DC.
Teal Action on Capitol Hill – March 10, 2015 – was powerful. More than 70 survivors and supporters from all over the country visited nearly 100 offices of members of either the United States Senate or the House of Representatives. I had the opportunity to talk to fabulous staffers working for Senators Wyden and Merkley, and for Representative Peter DeFazio who represents my district (Eugene, OR).
The advocates messages were loud and clear: continued funding for the Ovarian Cancer Research Program at the Department of Defense ($20 million) and for the Ovarian Cancer Control Initiative ($7.5 million) and Johanna’s Law ($5.5 million) at the Centers for Disease Control and Prevention, as well as increased funding for the National Cancer Institute ($5.4 billion) as part of enhanced funding for the National Institutes of Health. We also explained the importance of passage of the Cancer Drug Coverage Parity Act. This legislation would require health insurance companies to cover oral chemotherapy at the same rates (e.g., same copays or percentages) as for infusion chemotherapy.
Don’t just cross your fingers this all passes. Add your voice by letting your Congressional delegation know where you stand on these appropriations and issues. And next year – consider joining an inspiring group of women and our supporters on Advocacy Day. The Ovarian Cancer National Alliance (OCNA) staff do an excellent job of preparing us to be effective, to feel empowered, and to have fun!
Editor’s Note: Sandra (Sandi) traveled from Eugene to Washington DC in March to participate in the OCNA Advocacy Day.
Sandi was was diagnosed with Stage 3C ovarian cancer on September 11, 2013. Front-line treatment (dose dense carboplatin/taxol) brought her CA 125 to normal but she recurred six months later. After second line treatment (carboplatin/gemcitabine) that brought her CA 125 back down to normal she got two and a half months before it started to rise again.
Sandi is about to begin another round of chemo, this time Doxil (Doxorubicin). She is really hoping it works!